Fig. 15
From: Cell membrane-camouflaged inorganic nanoparticles for cancer therapy
a The synthesis process of [CSC-P]MNs and the principle of treatment. b The clearance after the first injection. c The accumulation amount of different NPs in different organs after the first injection. d The clearance rate of different NPs after the second injection. e The accumulation in different organs after the second injection. f The Fe content in RAW264.7 macrophage-like cells in cellular uptake experiment. g The Fe content in CAL27 cancer cells in cellular uptake experiment. Reprinted with permission from Refs [108]